Galena Biopharma and Leica Biosystems Announce Partnership to Develop Companion Diagnostic for HER2 Screening in Women With Breast Cancer

[at noodls] – Leica Biosystems will develop a fully automated HER2 diagnostic to support identification of appropriate HER2 negative (IHC 1+/2+) patients for NeuVaxâ„¢ (nelipepimut-S or E75) Galena strengthens its NeuVax … more

View todays social media effects on GALE

View the latest stocks trending across Twitter. Click to view dashboard

See who Galena is hiring next, click here to view